[jeremy.coyle@54.242.185.159] Executing task 'upload_to_ghap'
[jeremy.coyle@54.242.185.159] run: mkdir -p /tmp/cc88cff4-8b6c-4916-998c-9fefe4ba469d
Not going to clone git repo since it already exists
[jeremy.coyle@54.242.185.159] run: mkdir -p /tmp/edd378ec-63de-4d49-a708-4eeb9e159e9b
[jeremy.coyle@54.242.185.159] put: /tmp/tmpc6nn3ebo/script.Rmd -> /tmp/edd378ec-63de-4d49-a708-4eeb9e159e9b/script.Rmd
Put code at /tmp/edd378ec-63de-4d49-a708-4eeb9e159e9b/script.Rmd
[jeremy.coyle@54.242.185.159] put: /app/runner.R -> /tmp/edd378ec-63de-4d49-a708-4eeb9e159e9b/runner.R
[jeremy.coyle@54.242.185.159] put: /tmp/tmpc6nn3ebo/inputs.json -> /tmp/edd378ec-63de-4d49-a708-4eeb9e159e9b/inputs.json
Put inputs at /tmp/edd378ec-63de-4d49-a708-4eeb9e159e9b/inputs.json
Output PUT URL
https://tlapp.s3.amazonaws.com/cc88cff4-8b6c-4916-998c-9fefe4ba469d.tar.gz?AWSAccessKeyId=AKIAIROBNIBGQH5O7Q5A&Signature=c83tLCkKCBveARmUXaRJ1GPF9Zk%3D&Expires=1535246803
Command to run:
Rscript --default-packages=methods,stats,utils /tmp/edd378ec-63de-4d49-a708-4eeb9e159e9b/runner.R /tmp/edd378ec-63de-4d49-a708-4eeb9e159e9b/script.Rmd /tmp/edd378ec-63de-4d49-a708-4eeb9e159e9b/inputs.json /tmp/cc88cff4-8b6c-4916-998c-9fefe4ba469d
[jeremy.coyle@54.242.185.159] put: /tmp/tmpc6nn3ebo/x.py -> /tmp/edd378ec-63de-4d49-a708-4eeb9e159e9b/x.py
Put code at /tmp/edd378ec-63de-4d49-a708-4eeb9e159e9b/x.py
[jeremy.coyle@54.242.185.159] put: /tmp/tmpc6nn3ebo/wrapper.sh -> /tmp/edd378ec-63de-4d49-a708-4eeb9e159e9b/wrapper.sh
Put code at /tmp/edd378ec-63de-4d49-a708-4eeb9e159e9b/wrapper.sh
[jeremy.coyle@54.242.185.159] run: export TLAPP_TOKEN=*RBvH3ehiwubq?; export TLAPP_LOGS_URL=https://www.longbowapp.com/jobs/2260/append_log/; screen -d -m python x.py; sleep 1

  Natural language support but running in an English locale

R is a collaborative project with many contributors.
Type 'contributors()' for more information and
'citation()' on how to cite R or R packages in publications.

Type 'demo()' for some demos, 'help()' for on-line help, or
'help.start()' for an HTML browser interface to help.
Type 'q()' to quit R.

> if (!require('devtools')) install.packages('devtools', repos = 'http://cran.rstudio.com/')
> 
> 

R version 3.5.0 (2018-04-23) -- "Joy in Playing"
Copyright (C) 2018 The R Foundation for Statistical Computing
Platform: x86_64-redhat-linux-gnu (64-bit)

R is free software and comes with ABSOLUTELY NO WARRANTY.
You are welcome to redistribute it under certain conditions.
Type 'license()' or 'licence()' for distribution details.

  Natural language support but running in an English locale

R is a collaborative project with many contributors.
Type 'contributors()' for more information and
'citation()' on how to cite R or R packages in publications.

Type 'demo()' for some demos, 'help()' for on-line help, or
'help.start()' for an HTML browser interface to help.
Type 'q()' to quit R.

> if (!require('longbowtools')) devtools::install_github('tlverse/longbowtools')
> 
> 
Running provision script
Starting analysis


processing file: REPORT.Rmd
  |                                                                         |                                                                 |   0%  |                                                                         |..                                                               |   3%
  ordinary text without R code

  |                                                                         |....                                                             |   6%
label: setup (with options) 
List of 1
 $ include: logi FALSE

  |                                                                         |......                                                           |   9%
  ordinary text without R code

  |                                                                         |........                                                         |  12%
label: params (with options) 
List of 2
 $ warning: logi FALSE
 $ message: logi FALSE

Loading required package: graphics
trever_stuntedidc("meducyrs", "agecat", "studyid", "country")
TRUETRUEFALSENULL
  |                                                                         |..........                                                       |  16%
  ordinary text without R code

  |                                                                         |............                                                     |  19%
label: preprocessing
  |                                                                         |..............                                                   |  22%
   inline R code fragments

  |                                                                         |................                                                 |  25%
label: print_adjustment_set (with options) 
List of 1
 $ results: chr "asis"

  |                                                                         |..................                                               |  28%
  ordinary text without R code

  |                                                                         |....................                                             |  31%
label: print_strata_variables (with options) 
List of 1
 $ results: chr "asis"

  |                                                                         |......................                                           |  34%
  ordinary text without R code

  |                                                                         |........................                                         |  38%
label: data_summary
  |                                                                         |..........................                                       |  41%
  ordinary text without R code

  |                                                                         |............................                                     |  44%
label: print_strata (with options) 
List of 1
 $ results: chr "asis"

  |                                                                         |..............................                                   |  47%
  ordinary text without R code

  |                                                                         |................................                                 |  50%
label: drop_strata (with options) 
List of 1
 $ results: chr "asis"

  |                                                                         |...................................                              |  53%
  ordinary text without R code

  |                                                                         |.....................................                            |  56%
label: stratified_tmle (with options) 
List of 1
 $ message: logi FALSE

tmle for:	meducyrs: Q1, agecat: 0-24 months, studyid: iLiNS_DYADM_LNS, country: MALAWI
tmle for:	meducyrs: Q1, agecat: 0-24 months, studyid: ki1000110-WASH-Bangladesh, country: BANGLADESH
tmle for:	meducyrs: Q1, agecat: 0-24 months, studyid: ki1000111-WASH-Kenya, country: KENYA
tmle for:	meducyrs: Q1, agecat: 0-24 months, studyid: ki1000125-AgaKhanUniv, country: PAKISTAN
tmle for:	meducyrs: Q1, agecat: 0-24 months, studyid: ki1000304-EU, country: INDIA
tmle for:	meducyrs: Q1, agecat: 0-24 months, studyid: ki1000304-VITAMIN-A, country: INDIA
tmle for:	meducyrs: Q1, agecat: 0-24 months, studyid: ki1000304-Vitamin-B12, country: INDIA
tmle for:	meducyrs: Q1, agecat: 0-24 months, studyid: ki1000304-ZnMort, country: INDIA
tmle for:	meducyrs: Q1, agecat: 0-24 months, studyid: ki1000304b-SAS-CompFeed, country: INDIA
tmle for:	meducyrs: Q1, agecat: 0-24 months, studyid: ki1000304b-SAS-FoodSuppl, country: INDIA
tmle for:	meducyrs: Q1, agecat: 0-24 months, studyid: ki1017093b-PROVIDE, country: BANGLADESH
tmle for:	meducyrs: Q1, agecat: 0-24 months, studyid: ki1066203-TanzaniaChild2, country: TANZANIA, UNITED REPUBLIC OF
tmle for:	meducyrs: Q1, agecat: 0-24 months, studyid: ki1112895-Burkina Faso Zn, country: BURKINA FASO
outcome or treatment is constant. Skipping
tmle for:	meducyrs: Q1, agecat: 0-24 months, studyid: ki1112895-Guatemala BSC, country: GUATEMALA
tmle for:	meducyrs: Q1, agecat: 0-24 months, studyid: ki1126311-ZVITAMBO, country: ZIMBABWE
tmle for:	meducyrs: Q1, agecat: 0-24 months, studyid: ki1135781-COHORTS, country: GUATEMALA
tmle for:	meducyrs: Q1, agecat: 0-24 months, studyid: ki1148112-LCNI-5, country: MALAWI
tmle for:	meducyrs: Q1, agecat: 0-24 months, studyid: ki1148112-iLiNS-DOSE, country: MALAWI
tmle for:	meducyrs: Q1, agecat: 0-24 months, studyid: ki1148112-iLiNS-DYAD-M, country: MALAWI
tmle for:	meducyrs: Q1, agecat: 0-24 months, studyid: kiGH5241-JiVitA-3, country: BANGLADESH
tmle for:	meducyrs: Q1, agecat: 0-24 months, studyid: kiGH5241-JiVitA-4, country: BANGLADESH
tmle for:	meducyrs: Q1, agecat: 0-6 months, studyid: ki1000125-AgaKhanUniv, country: PAKISTAN
tmle for:	meducyrs: Q1, agecat: 0-6 months, studyid: ki1000304-VITAMIN-A, country: INDIA
tmle for:	meducyrs: Q1, agecat: 0-6 months, studyid: ki1000304-ZnMort, country: INDIA
tmle for:	meducyrs: Q1, agecat: 0-6 months, studyid: ki1000304b-SAS-CompFeed, country: INDIA
tmle for:	meducyrs: Q1, agecat: 0-6 months, studyid: ki1000304b-SAS-FoodSuppl, country: INDIA
tmle for:	meducyrs: Q1, agecat: 0-6 months, studyid: ki1017093b-PROVIDE, country: BANGLADESH
tmle for:	meducyrs: Q1, agecat: 0-6 months, studyid: ki1126311-ZVITAMBO, country: ZIMBABWE
tmle for:	meducyrs: Q1, agecat: 0-6 months, studyid: ki1135781-COHORTS, country: GUATEMALA
tmle for:	meducyrs: Q1, agecat: 0-6 months, studyid: ki1148112-LCNI-5, country: MALAWI
tmle for:	meducyrs: Q1, agecat: 0-6 months, studyid: ki1148112-iLiNS-DOSE, country: MALAWI
tmle for:	meducyrs: Q1, agecat: 0-6 months, studyid: kiGH5241-JiVitA-3, country: BANGLADESH
tmle for:	meducyrs: Q1, agecat: 0-6 months, studyid: kiGH5241-JiVitA-4, country: BANGLADESH
tmle for:	meducyrs: Q1, agecat: 6-24 months, studyid: iLiNS_DYADM_LNS, country: MALAWI
tmle for:	meducyrs: Q1, agecat: 6-24 months, studyid: ki1000110-WASH-Bangladesh, country: BANGLADESH
tmle for:	meducyrs: Q1, agecat: 6-24 months, studyid: ki1000111-WASH-Kenya, country: KENYA
tmle for:	meducyrs: Q1, agecat: 6-24 months, studyid: ki1000125-AgaKhanUniv, country: PAKISTAN
outcome or treatment is constant. Skipping
tmle for:	meducyrs: Q1, agecat: 6-24 months, studyid: ki1000304-EU, country: INDIA
tmle for:	meducyrs: Q1, agecat: 6-24 months, studyid: ki1000304-VITAMIN-A, country: INDIA
tmle for:	meducyrs: Q1, agecat: 6-24 months, studyid: ki1000304-ZnMort, country: INDIA
outcome or treatment is constant. Skipping
tmle for:	meducyrs: Q1, agecat: 6-24 months, studyid: ki1000304b-SAS-CompFeed, country: INDIA
tmle for:	meducyrs: Q1, agecat: 6-24 months, studyid: ki1000304b-SAS-FoodSuppl, country: INDIA
tmle for:	meducyrs: Q1, agecat: 6-24 months, studyid: ki1017093b-PROVIDE, country: BANGLADESH
tmle for:	meducyrs: Q1, agecat: 6-24 months, studyid: ki1112895-Burkina Faso Zn, country: BURKINA FASO
outcome or treatment is constant. Skipping
tmle for:	meducyrs: Q1, agecat: 6-24 months, studyid: ki1126311-ZVITAMBO, country: ZIMBABWE
tmle for:	meducyrs: Q1, agecat: 6-24 months, studyid: ki1135781-COHORTS, country: GUATEMALA
tmle for:	meducyrs: Q1, agecat: 6-24 months, studyid: ki1148112-LCNI-5, country: MALAWI
tmle for:	meducyrs: Q1, agecat: 6-24 months, studyid: ki1148112-iLiNS-DOSE, country: MALAWI
tmle for:	meducyrs: Q1, agecat: 6-24 months, studyid: ki1148112-iLiNS-DYAD-M, country: MALAWI
tmle for:	meducyrs: Q1, agecat: 6-24 months, studyid: kiGH5241-JiVitA-3, country: BANGLADESH
tmle for:	meducyrs: Q1, agecat: 6-24 months, studyid: kiGH5241-JiVitA-4, country: BANGLADESH
tmle for:	meducyrs: Q2, agecat: 0-24 months, studyid: iLiNS_DYADM_LNS, country: MALAWI
tmle for:	meducyrs: Q2, agecat: 0-24 months, studyid: ki1000110-WASH-Bangladesh, country: BANGLADESH
tmle for:	meducyrs: Q2, agecat: 0-24 months, studyid: ki1000304-EU, country: INDIA
tmle for:	meducyrs: Q2, agecat: 0-24 months, studyid: ki1000304-VITAMIN-A, country: INDIA
tmle for:	meducyrs: Q2, agecat: 0-24 months, studyid: ki1000304-Vitamin-B12, country: INDIA
tmle for:	meducyrs: Q2, agecat: 0-24 months, studyid: ki1000304-ZnMort, country: INDIA
tmle for:	meducyrs: Q2, agecat: 0-24 months, studyid: ki1000304b-SAS-CompFeed, country: INDIA
tmle for:	meducyrs: Q2, agecat: 0-24 months, studyid: ki1017093b-PROVIDE, country: BANGLADESH
tmle for:	meducyrs: Q2, agecat: 0-24 months, studyid: ki1066203-TanzaniaChild2, country: TANZANIA, UNITED REPUBLIC OF
tmle for:	meducyrs: Q2, agecat: 0-24 months, studyid: ki1112895-Burkina Faso Zn, country: BURKINA FASO
outcome or treatment is constant. Skipping
tmle for:	meducyrs: Q2, agecat: 0-24 months, studyid: ki1112895-Guatemala BSC, country: GUATEMALA
tmle for:	meducyrs: Q2, agecat: 0-24 months, studyid: ki1119695-PROBIT, country: BELARUS
tmle for:	meducyrs: Q2, agecat: 0-24 months, studyid: ki1126311-ZVITAMBO, country: ZIMBABWE
tmle for:	meducyrs: Q2, agecat: 0-24 months, studyid: ki1135781-COHORTS, country: GUATEMALA
tmle for:	meducyrs: Q2, agecat: 0-24 months, studyid: ki1148112-LCNI-5, country: MALAWI
tmle for:	meducyrs: Q2, agecat: 0-24 months, studyid: ki1148112-iLiNS-DOSE, country: MALAWI
tmle for:	meducyrs: Q2, agecat: 0-24 months, studyid: ki1148112-iLiNS-DYAD-M, country: MALAWI
tmle for:	meducyrs: Q2, agecat: 0-24 months, studyid: kiGH5241-JiVitA-3, country: BANGLADESH
tmle for:	meducyrs: Q2, agecat: 0-6 months, studyid: ki1000304-VITAMIN-A, country: INDIA
tmle for:	meducyrs: Q2, agecat: 0-6 months, studyid: ki1000304-ZnMort, country: INDIA
tmle for:	meducyrs: Q2, agecat: 0-6 months, studyid: ki1000304b-SAS-CompFeed, country: INDIA
tmle for:	meducyrs: Q2, agecat: 0-6 months, studyid: ki1000304b-SAS-FoodSuppl, country: INDIA
tmle for:	meducyrs: Q2, agecat: 0-6 months, studyid: ki1017093b-PROVIDE, country: BANGLADESH
tmle for:	meducyrs: Q2, agecat: 0-6 months, studyid: ki1066203-TanzaniaChild2, country: TANZANIA, UNITED REPUBLIC OF
tmle for:	meducyrs: Q2, agecat: 0-6 months, studyid: ki1119695-PROBIT, country: BELARUS
tmle for:	meducyrs: Q2, agecat: 0-6 months, studyid: ki1126311-ZVITAMBO, country: ZIMBABWE
tmle for:	meducyrs: Q2, agecat: 0-6 months, studyid: ki1135781-COHORTS, country: GUATEMALA
tmle for:	meducyrs: Q2, agecat: 0-6 months, studyid: ki1148112-iLiNS-DOSE, country: MALAWI
tmle for:	meducyrs: Q2, agecat: 0-6 months, studyid: kiGH5241-JiVitA-3, country: BANGLADESH
tmle for:	meducyrs: Q2, agecat: 6-24 months, studyid: iLiNS_DYADM_LNS, country: MALAWI
tmle for:	meducyrs: Q2, agecat: 6-24 months, studyid: ki1000110-WASH-Bangladesh, country: BANGLADESH
tmle for:	meducyrs: Q2, agecat: 6-24 months, studyid: ki1000304-EU, country: INDIA
tmle for:	meducyrs: Q2, agecat: 6-24 months, studyid: ki1000304-VITAMIN-A, country: INDIA
tmle for:	meducyrs: Q2, agecat: 6-24 months, studyid: ki1000304-ZnMort, country: INDIA
outcome or treatment is constant. Skipping
tmle for:	meducyrs: Q2, agecat: 6-24 months, studyid: ki1000304b-SAS-CompFeed, country: INDIA
tmle for:	meducyrs: Q2, agecat: 6-24 months, studyid: ki1017093b-PROVIDE, country: BANGLADESH
tmle for:	meducyrs: Q2, agecat: 6-24 months, studyid: ki1066203-TanzaniaChild2, country: TANZANIA, UNITED REPUBLIC OF
tmle for:	meducyrs: Q2, agecat: 6-24 months, studyid: ki1112895-Burkina Faso Zn, country: BURKINA FASO
outcome or treatment is constant. Skipping
tmle for:	meducyrs: Q2, agecat: 6-24 months, studyid: ki1112895-Guatemala BSC, country: GUATEMALA
tmle for:	meducyrs: Q2, agecat: 6-24 months, studyid: ki1119695-PROBIT, country: BELARUS
tmle for:	meducyrs: Q2, agecat: 6-24 months, studyid: ki1126311-ZVITAMBO, country: ZIMBABWE
tmle for:	meducyrs: Q2, agecat: 6-24 months, studyid: ki1135781-COHORTS, country: GUATEMALA
tmle for:	meducyrs: Q2, agecat: 6-24 months, studyid: ki1148112-LCNI-5, country: MALAWI
tmle for:	meducyrs: Q2, agecat: 6-24 months, studyid: ki1148112-iLiNS-DOSE, country: MALAWI
tmle for:	meducyrs: Q2, agecat: 6-24 months, studyid: ki1148112-iLiNS-DYAD-M, country: MALAWI
tmle for:	meducyrs: Q2, agecat: 6-24 months, studyid: kiGH5241-JiVitA-3, country: BANGLADESH
tmle for:	meducyrs: Q3, agecat: 0-24 months, studyid: iLiNS_DYADM_LNS, country: MALAWI
tmle for:	meducyrs: Q3, agecat: 0-24 months, studyid: ki1000110-WASH-Bangladesh, country: BANGLADESH
tmle for:	meducyrs: Q3, agecat: 0-24 months, studyid: ki1000111-WASH-Kenya, country: KENYA
tmle for:	meducyrs: Q3, agecat: 0-24 months, studyid: ki1000304-EU, country: INDIA
tmle for:	meducyrs: Q3, agecat: 0-24 months, studyid: ki1000304-VITAMIN-A, country: INDIA
tmle for:	meducyrs: Q3, agecat: 0-24 months, studyid: ki1000304-Vitamin-B12, country: INDIA
tmle for:	meducyrs: Q3, agecat: 0-24 months, studyid: ki1000304-ZnMort, country: INDIA
tmle for:	meducyrs: Q3, agecat: 0-24 months, studyid: ki1000304b-SAS-CompFeed, country: INDIA
tmle for:	meducyrs: Q3, agecat: 0-24 months, studyid: ki1017093b-PROVIDE, country: BANGLADESH
tmle for:	meducyrs: Q3, agecat: 0-24 months, studyid: ki1112895-Guatemala BSC, country: GUATEMALA
tmle for:	meducyrs: Q3, agecat: 0-24 months, studyid: ki1119695-PROBIT, country: BELARUS
tmle for:	meducyrs: Q3, agecat: 0-24 months, studyid: ki1126311-ZVITAMBO, country: ZIMBABWE
tmle for:	meducyrs: Q3, agecat: 0-24 months, studyid: ki1148112-iLiNS-DOSE, country: MALAWI
tmle for:	meducyrs: Q3, agecat: 0-24 months, studyid: ki1148112-iLiNS-DYAD-M, country: MALAWI
tmle for:	meducyrs: Q3, agecat: 0-24 months, studyid: kiGH5241-JiVitA-3, country: BANGLADESH
tmle for:	meducyrs: Q3, agecat: 0-24 months, studyid: kiGH5241-JiVitA-4, country: BANGLADESH
tmle for:	meducyrs: Q3, agecat: 0-6 months, studyid: ki1000304b-SAS-CompFeed, country: INDIA
tmle for:	meducyrs: Q3, agecat: 0-6 months, studyid: ki1017093b-PROVIDE, country: BANGLADESH
tmle for:	meducyrs: Q3, agecat: 0-6 months, studyid: ki1119695-PROBIT, country: BELARUS
tmle for:	meducyrs: Q3, agecat: 0-6 months, studyid: ki1126311-ZVITAMBO, country: ZIMBABWE
tmle for:	meducyrs: Q3, agecat: 0-6 months, studyid: ki1148112-iLiNS-DOSE, country: MALAWI
tmle for:	meducyrs: Q3, agecat: 0-6 months, studyid: kiGH5241-JiVitA-3, country: BANGLADESH
tmle for:	meducyrs: Q3, agecat: 6-24 months, studyid: iLiNS_DYADM_LNS, country: MALAWI
tmle for:	meducyrs: Q3, agecat: 6-24 months, studyid: ki1000110-WASH-Bangladesh, country: BANGLADESH
tmle for:	meducyrs: Q3, agecat: 6-24 months, studyid: ki1000111-WASH-Kenya, country: KENYA
tmle for:	meducyrs: Q3, agecat: 6-24 months, studyid: ki1000304-ZnMort, country: INDIA
outcome or treatment is constant. Skipping
tmle for:	meducyrs: Q3, agecat: 6-24 months, studyid: ki1000304b-SAS-CompFeed, country: INDIA
tmle for:	meducyrs: Q3, agecat: 6-24 months, studyid: ki1119695-PROBIT, country: BELARUS
tmle for:	meducyrs: Q3, agecat: 6-24 months, studyid: ki1126311-ZVITAMBO, country: ZIMBABWE
tmle for:	meducyrs: Q3, agecat: 6-24 months, studyid: ki1148112-iLiNS-DOSE, country: MALAWI
tmle for:	meducyrs: Q3, agecat: 6-24 months, studyid: ki1148112-iLiNS-DYAD-M, country: MALAWI
tmle for:	meducyrs: Q3, agecat: 6-24 months, studyid: kiGH5241-JiVitA-3, country: BANGLADESH
tmle for:	meducyrs: Q4, agecat: 0-24 months, studyid: iLiNS_DYADM_LNS, country: MALAWI
tmle for:	meducyrs: Q4, agecat: 0-24 months, studyid: ki1000110-WASH-Bangladesh, country: BANGLADESH
tmle for:	meducyrs: Q4, agecat: 0-24 months, studyid: ki1000111-WASH-Kenya, country: KENYA
tmle for:	meducyrs: Q4, agecat: 0-24 months, studyid: ki1000304-EU, country: INDIA
tmle for:	meducyrs: Q4, agecat: 0-24 months, studyid: ki1000304-VITAMIN-A, country: INDIA
tmle for:	meducyrs: Q4, agecat: 0-24 months, studyid: ki1000304-Vitamin-B12, country: INDIA
tmle for:	meducyrs: Q4, agecat: 0-24 months, studyid: ki1112895-Burkina Faso Zn, country: BURKINA FASO
outcome or treatment is constant. Skipping
tmle for:	meducyrs: Q4, agecat: 0-24 months, studyid: ki1112895-Guatemala BSC, country: GUATEMALA
tmle for:	meducyrs: Q4, agecat: 0-24 months, studyid: ki1119695-PROBIT, country: BELARUS
tmle for:	meducyrs: Q4, agecat: 0-24 months, studyid: ki1126311-ZVITAMBO, country: ZIMBABWE
tmle for:	meducyrs: Q4, agecat: 0-24 months, studyid: ki1148112-iLiNS-DOSE, country: MALAWI
tmle for:	meducyrs: Q4, agecat: 0-24 months, studyid: ki1148112-iLiNS-DYAD-M, country: MALAWI
tmle for:	meducyrs: Q4, agecat: 0-24 months, studyid: kiGH5241-JiVitA-3, country: BANGLADESH
tmle for:	meducyrs: Q4, agecat: 0-6 months, studyid: ki1112895-Guatemala BSC, country: GUATEMALA
tmle for:	meducyrs: Q4, agecat: 0-6 months, studyid: ki1119695-PROBIT, country: BELARUS
tmle for:	meducyrs: Q4, agecat: 0-6 months, studyid: ki1126311-ZVITAMBO, country: ZIMBABWE
tmle for:	meducyrs: Q4, agecat: 0-6 months, studyid: ki1148112-iLiNS-DOSE, country: MALAWI
tmle for:	meducyrs: Q4, agecat: 0-6 months, studyid: kiGH5241-JiVitA-3, country: BANGLADESH
tmle for:	meducyrs: Q4, agecat: 6-24 months, studyid: iLiNS_DYADM_LNS, country: MALAWI
tmle for:	meducyrs: Q4, agecat: 6-24 months, studyid: ki1000110-WASH-Bangladesh, country: BANGLADESH
tmle for:	meducyrs: Q4, agecat: 6-24 months, studyid: ki1000111-WASH-Kenya, country: KENYA
tmle for:	meducyrs: Q4, agecat: 6-24 months, studyid: ki1000304-EU, country: INDIA
outcome or treatment is constant. Skipping
tmle for:	meducyrs: Q4, agecat: 6-24 months, studyid: ki1112895-Burkina Faso Zn, country: BURKINA FASO
outcome or treatment is constant. Skipping
tmle for:	meducyrs: Q4, agecat: 6-24 months, studyid: ki1119695-PROBIT, country: BELARUS
tmle for:	meducyrs: Q4, agecat: 6-24 months, studyid: ki1126311-ZVITAMBO, country: ZIMBABWE
tmle for:	meducyrs: Q4, agecat: 6-24 months, studyid: ki1148112-iLiNS-DOSE, country: MALAWI
tmle for:	meducyrs: Q4, agecat: 6-24 months, studyid: ki1148112-iLiNS-DYAD-M, country: MALAWI
tmle for:	meducyrs: Q4, agecat: 6-24 months, studyid: kiGH5241-JiVitA-3, country: BANGLADESH
  |                                                                         |.......................................                          |  59%
  ordinary text without R code

  |                                                                         |.........................................                        |  62%
label: save_results
  |                                                                         |...........................................                      |  66%
  ordinary text without R code

  |                                                                         |.............................................                    |  69%
label: plot_tsm (with options) 
List of 2
 $ warning: logi FALSE
 $ message: logi FALSE

  |                                                                         |...............................................                  |  72%
  ordinary text without R code

  |                                                                         |.................................................                |  75%
label: plot_rr (with options) 
List of 2
 $ warning: logi FALSE
 $ message: logi FALSE

  |                                                                         |...................................................              |  78%
  ordinary text without R code

  |                                                                         |.....................................................            |  81%
label: plot_ate (with options) 
List of 2
 $ warning: logi FALSE
 $ message: logi FALSE

  |                                                                         |.......................................................          |  84%
  ordinary text without R code

  |                                                                         |.........................................................        |  88%
label: plot_paf (with options) 
List of 2
 $ warning: logi FALSE
 $ message: logi FALSE

  |                                                                         |...........................................................      |  91%
  ordinary text without R code

  |                                                                         |.............................................................    |  94%
label: plot_par (with options) 
List of 2
 $ warning: logi FALSE
 $ message: logi FALSE

{"status": "success"}
